Literature DB >> 1864537

Microscopic activity in ulcerative colitis: what does it mean?

S A Riley1, V Mani, M J Goodman, S Dutt, M E Herd.   

Abstract

To determine the prognostic importance of microscopic rectal inflammation we followed up 82 patients (aged 21 to 78 years, 44 men) with chronic quiescent ulcerative colitis over 12 months. At trial entry each patient underwent a rectal biopsy and sections were graded independently by two histopathologists. A chronic inflammatory cell infiltrate of varying severity was present in all biopsy specimens, and 58% had crypt architectural irregularities. In addition, 32% had evidence of acute inflammatory activity: 28% acute inflammatory cell infiltrate, 11% crypt abscesses, and 22% mucin depletion. Agreement between the two histopathologists for the presence of each of these features was 94% (90-98%). During the 12 month follow up 27 patients (33%) relapsed after a mean interval of 18 weeks (range 3-44 weeks). Relapse rates were unrelated to duration or extent of disease or to the type of maintenance drug treatment. In patients with an acute inflammatory cell infiltrate 52% relapsed, whereas in the absence of such an infiltrate only 25% relapsed (p = 0.02). Similarly, relapse rates were higher in the presence of crypt abscesses (78% v 27%, p less than 0.005), mucin depletion (56% v p less than 0.02), and breaches in the surface epithelium (75% v 31%, p = 0.1). The presence of a chronic inflammatory cell infiltrate or crypt architectural irregularities, however, bore no relation to the frequency of colitis relapse.

Entities:  

Mesh:

Year:  1991        PMID: 1864537      PMCID: PMC1378803          DOI: 10.1136/gut.32.2.174

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.

Authors:  J H BARON; A M CONNELL; J E LENNARD-JONES
Journal:  Br Med J       Date:  1964-01-11

2.  Biopsy studies in ulcerative colitis.

Authors:  S C TRUELOVE; W C RICHARDS
Journal:  Br Med J       Date:  1956-06-09

3.  Sigmoidoscopy and cytology in the detection of microscopic disease of the rectal mucosa in ulcerative colitis.

Authors:  J M Watts; H Thompson; J C Goligher
Journal:  Gut       Date:  1966-06       Impact factor: 23.059

4.  The value of rectal biopsy in the diagnosis of ulcerative colitis.

Authors:  S G MATTS
Journal:  Q J Med       Date:  1961-10

Review 5.  Rectal biopsy in inflammatory bowel disease.

Authors:  B C Morson
Journal:  N Engl J Med       Date:  1972-12-28       Impact factor: 91.245

6.  A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.

Authors:  V Binder
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

7.  Mucosal-cell counts in ulcerative and granulomatous colitis.

Authors:  S C Sommers; B I Korelitz
Journal:  Am J Clin Pathol       Date:  1975-03       Impact factor: 2.493

8.  Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets.

Authors:  R Wright; S R Truelove
Journal:  Am J Dig Dis       Date:  1966-11

9.  Persistence of mucosal abnormality in ulcerative colitis.

Authors:  A P Dick; L P Holt; E R Dalton
Journal:  Gut       Date:  1966-08       Impact factor: 23.059

10.  A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin).

Authors:  A S Dissanayake; S C Truelove
Journal:  Gut       Date:  1973-12       Impact factor: 23.059

View more
  119 in total

1.  Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Authors:  D Ludwig; S Wiener; A Brüning; K Schwarting; G Jantschek; K Fellermann; M Stahl; E F Stange
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

2.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 3.  Mucosal healing in inflammatory bowel disease: where do we stand?

Authors:  Christina Ha; Asher Kornbluth
Journal:  Curr Gastroenterol Rep       Date:  2010-12

4.  Quantification of autofluorescence imaging can accurately and objectively assess the severity of ulcerative colitis.

Authors:  Kentaro Moriichi; Mikihiro Fujiya; Masami Ijiri; Kazuyuki Tanaka; Aki Sakatani; Tatsuya Dokoshi; Shugo Fujibayashi; Katsuyoshi Ando; Yoshiki Nomura; Nobuhiro Ueno; Shin Kashima; Takuma Gotoh; Junpei Sasajima; Yuhei Inaba; Takahiro Ito; Hiroki Tanabe; Yusuke Saitoh; Yutaka Kohgo
Journal:  Int J Colorectal Dis       Date:  2015-08-13       Impact factor: 2.571

5.  Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.

Authors:  Y Nishio; T Ando; O Maeda; K Ishiguro; O Watanabe; N Ohmiya; Y Niwa; K Kusugami; H Goto
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

6.  Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.

Authors:  Amanda Israel; Britt Christensen; Katia El Jurdi; Victoria Rai; Jacob E Ollech; Russell D Cohen; Atsushi Sakuraba; Sushila R Dalal; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-20       Impact factor: 11.382

7.  European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; C Beglinger; L Kupcinkas; K Geboes; A Barakauskiene; V Villanacci; A Von Herbay; B F Warren; C Gasche; H Tilg; Stefan W Schreiber; J Schölmerich; W Reinisch
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

8.  Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.

Authors:  Burton I Korelitz; Keith Sultan; Megha Kothari; Leo Arapos; Judy Schneider; Georgia Panagopoulos
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

9.  Calprotectin as a diagnostic tool for inflammatory bowel diseases.

Authors:  Marianthi Chatzikonstantinou; Panagiotis Konstantopoulos; Spyros Stergiopoulos; Konstantinos Kontzoglou; Christos Verikokos; Despina Perrea; Dimitris Dimitroulis
Journal:  Biomed Rep       Date:  2016-09-07

10.  Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine.

Authors:  K Fukushima; G West; C Fiocchi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.